Rheumatoid arthritis associated nuclear antigen (RANA) and Epstein-Barr virus (EBV)
Li, Z.G.
Zhonghua Yi Xue Za Zhi 68(8): 447-449; 32
1988
ISSN/ISBN: 0376-2491 PMID: 2852534 Document Number: 325430
Document emailed within 1 workday
Related Documents
Klein, G.; Vonka, V. 1974: Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence Journal of the National Cancer Institute 53(6): 1645-1646Xu, W.D.; Shi, G.Y.; Cai, X.H. 1985: The relationship between Epstein-Barr virus and rheumatoid arthritis Zhonghua Nei Ke Za Zhi 24(8): 457-459; 509
Thomason, R.W.; Craig, F.E.; Banks, P.M.; Sears, D.L.; Myerson, G.E.; Gulley, M.L. 1996: Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(3): 261-266
Anan'eva, L.P.; Alekberova, Z.S.; Stepina, V.N. 1989: The humoral immune response to Epstein-Barr virus in rheumatoid arthritis Vestnik Akademii Meditsinskikh Nauk SSSR 6: 76-79
Starkebaum, G. 2001: Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus? Journal of Rheumatology 28(12): 2573-2575
Klatt, T.; Ouyang, Q.; Flad, T.; Koetter, I.; Bühring, H-Jörg.; Kalbacher, H.; Pawelec, G.; Müller, C.A. 2005: Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis Journal of Rheumatology 32(2): 239-251
Le Goff, P.; Chicault, P.; Saraux, A.; Baron, D.; Valls-Bellec, I.; Leroy, J.P. 1998: Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus Revue du Rhumatisme 65(4): 283-286
Lioté, F.; Pertuiset, E.; Cochand-Priollet, B.; D'Agay, M.F.; Dombret, H.; Numéric, P.; D'Anglejan, G.; Kuntz, D. 1995: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection Journal of Rheumatology 22(6): 1174-1178
Laux, G.; Adam, B.; Strobl, L.J.; Moreau-Gachelin, F. 1994: The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element EMBO Journal 13(23): 5624-5632
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Schenk, B.I.; Michel, P.O.; Enders, G.; Thilo, N.; Radtke, M.; Oker, C.-Blom; Franke, D. 2007: Evaluation of a New ELISA for the Detection of Specific IgG to the Epstein-Barr Nuclear Antigen 1 (EBNA-1) Clinical Laboratory 53(3-4): 151-155
Hamilton-Dutoit, S.J.; Pallesen, G. 1992: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas American Journal of Pathology 140(6): 1315-1325
Törnell, J.; Farzad, S.; Espander-Jansson, A.; Matejka, G.; Isaksson, O.; Rymo, L. 1996: Expression of Epstein-Barr nuclear antigen 2 in kidney tubule cells induce tumors in transgenic mice Oncogene 12(7): 1521-1528
Lynn, T.C.; Hsu, M.M.; Hsieh, T.; Tu, S.M.; Hamajima, K. 1976: Nasopharyngeal carcinoma and Epstein-Barr virus. III. the detection of anti-nuclear antibodies Japanese Journal of Experimental Medicine 46(5): 289-295
Yang, T.-t.; Wang, Y.; Liu, X.; Li, X.; Pang, Z.-c.; Luo, B. 2009: Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma Bing du Xue Bao 25(1): 29-34
Schuchmann, L.; Neumann-Haefelin, D. 1985: Persistent (chronic active) Epstein-Barr virus infection and arthritis in childhood Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 133(11): 845-847
Henle, G.; Lennette, E.T.; Alspaugh, M.A.; Henle, W. 1979: Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies Clinical and Experimental Immunology 36(3): 415-422
Friedrich, R.E.; Bartel-Friedrich, S.; Lobeck, H.; Niedobitek, G.; Arps, H. 2000: Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma Anticancer Research 20(6d): 4909-4916
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Votava, M.; Bartosová, D.; Krchnáková, A.; Crhová, K.; Kubinová, L. 1996: Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children Acta Virologica 40(2): 99-101